Literature DB >> 11725487

Cdk pathway: cyclin-dependent kinases and cyclin-dependent kinase inhibitors.

D M Gitig1, A Koff.   

Abstract

Many mechanisms either activate or inhibit the cdks and thereby either promote or arrest progression through the mitotic cell cycle. Since the signal transduction pathways emanating from extracellular mitogens and the agents controlling these pathways are complicated there may yet be novel mechanisms of cell cycle regulation remaining to be elucidated. In this article we outline the different techniques used to study the cell cycle and its regulation. These include: establishing that the cell cycle is arrested by propidium iodide staining followed by FACS analysis or by measuring 3H-thymidine incorporation into DNA; measuring the amount of cyclin/cdk associated kinase activity; assessing the steady-state expression profiles of cyclins, cdks and ckis by immunoblotting; and investigating the formation of complexes between these proteins by coimmunoprecipitations. Caveats and advantages of each technique are discussed. Following this paradigm yielded the discovery of the cell cycle inhibitors p27Kip1 and p21Cip1 and could very well lead to the discovery or novel cell cycle regulatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11725487     DOI: 10.1385/MB:19:2:179

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  10 in total

1.  Human T-cell leukemia virus type 1 Tax and cell cycle progression: role of cyclin D-cdk and p110Rb.

Authors:  C Neuveut; K G Low; F Maldarelli; I Schmitt; F Majone; R Grassmann; K T Jeang
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

2.  Formation of p27-CDK complexes during the human mitotic cell cycle.

Authors:  T J Soos; H Kiyokawa; J S Yan; M S Rubin; A Giordano; A DeBlasio; S Bottega; B Wong; J Mendelsohn; A Koff
Journal:  Cell Growth Differ       Date:  1996-02

Review 3.  The regulation of E2F by pRB-family proteins.

Authors:  N Dyson
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

4.  Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts.

Authors:  N Takuwa; Y Takuwa
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

5.  Cooperating oncogenes converge to regulate cyclin/cdk complexes.

Authors:  A C Lloyd; F Obermüller; S Staddon; C F Barth; M McMahon; H Land
Journal:  Genes Dev       Date:  1997-03-01       Impact factor: 11.361

6.  Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution.

Authors:  M D Planas-Silva; R A Weinberg
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

7.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

Authors:  K Polyak; J Y Kato; M J Solomon; C J Sherr; J Massague; J M Roberts; A Koff
Journal:  Genes Dev       Date:  1994-01       Impact factor: 11.361

8.  Requirement of cyclin E-Cdk2 inhibition in p16(INK4a)-mediated growth suppression.

Authors:  H Jiang; H S Chou; L Zhu
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

9.  Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.

Authors:  A Koff; M Ohtsuki; K Polyak; J M Roberts; J Massagué
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

10.  Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes.

Authors:  E J Firpo; A Koff; M J Solomon; J M Roberts
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

  10 in total
  3 in total

1.  Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins.

Authors:  Yongxing Gong; Travis Ian Zack; Luc G T Morris; Kan Lin; Ellen Hukkelhoven; Radhika Raheja; I-Li Tan; Sevin Turcan; Selvaraju Veeriah; Shasha Meng; Agnes Viale; Steven E Schumacher; Perry Palmedo; Rameen Beroukhim; Timothy A Chan
Journal:  Nat Genet       Date:  2014-05-04       Impact factor: 38.330

2.  Anoxic fibroblasts activate a replication checkpoint that is bypassed by E1a.

Authors:  Lawrence B Gardner; Feng Li; Xuejie Yang; Chi V Dang
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

3.  Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis.

Authors:  David Johansson; Eldina Kosovac; Jasmin Moharer; Ingrid Ljuslinder; Thomas Brännström; Anders Johansson; Parviz Behnam-Motlagh
Journal:  BMC Cancer       Date:  2009-02-26       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.